{
    "medicine_id": "58a5184cd289b6bf37606eca2ed6947806883630",
    "platform_id": "DB01344",
    "metadata": {
        "name": "Jamp Calcium Polystyrene Sulfonate 5 g Powder for suspension",
        "composition": "5 g Tolevamer",
        "clinical_particulars": {
            "therapeutic_indications": "Used to treat abnormally high potassium levels",
            "contraindications": {
                "disease": "Overdose symptoms may include confusion irritability trouble thinking or concentrating muscle weakness or trouble breathing",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Polystyrene sulfonate affects the exchange of sodium and potassium in the body Polystyrene sulfonate is used to treat high levels of potassium in the blood also called hyperkalemia It is a potassium binding ion exchange resin that can be administered orally 25 grams in 20 sorbitol or rectally 50 grams in 20 sorbitol",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01377",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01390",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Sodium bicarbonate"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Calcium carbonate"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magaldrate"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium hydroxide"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium trisilicate"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium carbonate"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Aluminium acetoacetate"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Hydrotalcite"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium peroxide"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Almasilate"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Aluminium glycinate"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Aloglutamol"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Calcium silicate"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Aluminium phosphate"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "Tolevamer can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Tolevamer can cause a decrease in the absorption of Liothyronine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "Tolevamer can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "Tolevamer can cause a decrease in the absorption of Liotrix resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "Tolevamer can cause a decrease in the absorption of Tiratricol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "Tolevamer can cause a decrease in the absorption of Thyroid porcine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Digoxin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Ouabain"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Oleandrin"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Cymarin"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Proscillaridin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Lanatoside C"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Gitoformate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Peruvoside"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of adverse effects can be increased when Meloxicam is combined with Tolevamer"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "The absorption of Lithium citrate can be decreased when combined with Tolevamer"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The absorption of Lithium carbonate can be decreased when combined with Tolevamer"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "The absorption of Lithium hydroxide can be decreased when combined with Tolevamer"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Nizatidine"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Famotidine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Methantheline"
                    },
                    {
                        "drugbank-id": "DB08805",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Metiamide"
                    },
                    {
                        "drugbank-id": "DB08806",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Roxatidine acetate"
                    },
                    {
                        "drugbank-id": "DB12770",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Lafutidine"
                    },
                    {
                        "drugbank-id": "DB12884",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Lavoltidine"
                    },
                    {
                        "drugbank-id": "DB13760",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Niperotidine"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Pantoprazole"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00736",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Esomeprazole"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB05351",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Dexlansoprazole"
                    },
                    {
                        "drugbank-id": "DB13762",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Dexrabeprazole"
                    },
                    {
                        "drugbank-id": "DB15246",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Salvianolic acid A"
                    },
                    {
                        "drugbank-id": "DB14048",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Sodium zirconium cyclosilicate"
                    },
                    {
                        "drugbank-id": "DB01370",
                        "description": "The therapeutic efficacy of Tolevamer can be decreased when used in combination with Aluminium"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Tolevamer may decrease effectiveness of Technetium Tc 99m oxidronate as a diagnostic agent"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}